Tomoko Nagai
-
- T-cell and Retrovirus Studies 4
- Immunodeficiency and Autoimmune Disorders 4
-
- Acute Myeloid Leukemia Research 3
-
- Chronic Lymphocytic Leukemia Research 5
- Blood disorders and treatments 3
-
- Lymphoma Diagnosis and Treatment 9
-
- Cerebral Palsy and Movement Disorders 3
-
- Monoclonal and Polyclonal Antibodies Research 3
- Co-authors
- Rie TabataChiharu TabataMakoto TeradaNobuhiro NoroHaruto UchinoJunji YodoiTakateru IzumiMitsufumi Mayumi
- Cited by
- ImmunologyNephrologyHematology
- Partner nations
- JapanUnited Kingdom
In The Last Decade
Tomoko Nagai
41 papers receiving 298 citations
Peers
Comparison fields: 5 of 80
- Immunology 108
- Nephrology 34
- Hematology 41
- Biological Psychiatry 7
- Genetics 27
Countries citing papers authored by Tomoko Nagai
This map shows the geographic impact of Tomoko Nagai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoko Nagai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoko Nagai more than expected).
Fields of papers citing papers by Tomoko Nagai
This network shows the impact of papers produced by Tomoko Nagai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoko Nagai. The network helps show where Tomoko Nagai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tomoko Nagai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 0 | |
| 2 | 2016 | 17 | |
| 3 | 2016 | 2 | |
| 4 | 2014 | 2 | |
| 5 | 2014 | 9 | |
| 6 | 2014 | 5 | |
| 7 | 2013 | 13 | |
| 8 | 2012 | 21 | |
| 9 | 2011 | 1 | |
| 10 | 2010 | 6 | |
| 11 | 2009 | 19 | |
| 12 | 2009 | 9 | |
| 13 | 2007 | 5 | |
| 14 | 2006 | 1 | |
| 15 | Necessity of correcting cancer antigen 125 appearance rates by body surface area. | 2000 | 8 |
| 16 | 1995 | 22 | |
| 17 | [Clinical evaluation of immunoscintigraphy with 131I anti-CEA and 131I anti-CA 19-9 monoclonal antibody cocktail (IMACIS-1)--report of the phase II study]. | 1990 | 2 |
| 18 | [IBL like T cell lymphoma associated with hemolytic anemia and polyploidy chromosomal abnormality--a case report]. | 1990 | 1 |
| 19 | 1986 | 9 | |
| 20 | PPD-induced immunoglobulin production in human peripheral blood lymphocytes. I. Necessary conditions for inducing the response. | 1979 | 20 |
About Tomoko Nagai
Tomoko Nagai is a scholar working on Hematology, Immunology and Pathology and Forensic Medicine, having authored 45 papers that have together received 316 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (5 papers), T-cell and Retrovirus Studies (4 papers), Immunodeficiency and Autoimmune Disorders (4 papers), Blood disorders and treatments (3 papers), Cerebral Palsy and Movement Disorders (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Immunology (108 citations), Nephrology (34 citations) and Hematology (41 citations). Tomoko Nagai has collaborated with scholars based in Japan and United Kingdom. Frequent co-authors include Rie Tabata, Chiharu Tabata, Makoto Terada, Nobuhiro Noro, Haruto Uchino, Junji Yodoi, Takateru Izumi, Mitsufumi Mayumi, Shin‐Ichi Nishikawa and Misaki Moriishi. Their work appears in journals such as Blood, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.